D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation

American Journal of the Medical Sciences

Volumn 349, Issue 1, 2015, Pages 29-35

  Fruchter, Oren ^a   Yigla, Mordechai ^b   Kramer, Mordechai R ^c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; BLOOD; EPIDEMIOLOGY; ISRAEL; MIDDLE AGED; VENOUS THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HOSPITAL MORTALITY; HUMANS; ISRAEL; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VENOUS THROMBOSIS;

EID: 84927934278     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/maj.0000000000000332     Document Type: Article

References (28)

1. Halpern MT, Stanford RH, Borker R. The burden of COPD in the USA: results from the confronting COPD survey. Respir Med 2003;97 (suppl C):S81-9.
2. Chiang CH. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Respirology 2008;13:689-94.
3. Roberts CM, Lowe D, Bucknall CE, et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002;57:137-41.
4. Miravitlles M, Guerrero T, Mayordomo C, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000;67:495-501.
5. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortalityrelated factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459-67.
6. Karadag F, Karul AB, Cildag O, et al. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008; 186:403-9.
7. Snell N, Newbold P. The clinical utility of biomarkers in asthma and COPD. Curr Opin Pharmacol 2008;8:222-35.
8. O'Reilly P, Bailey W. Clinical use of exhaled biomarkers in COPD. Int J Chron Obstruct Pulmon Dis 2007;2:403-8.
9. Fabbri LM, Luppi F, Beghé B, et al. Complex chronic comorbidities of COPD. Eur Respir J 2008;31:204-12.
10. Sin DD, Man SF. Biomarkers in COPD: are we there yet? Chest 2008; 133:1296-8.
11. Alessandri C, Basili S, Violi F, et al. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic obstructive bronchitis and haemostasis group. Thromb Haemost 1994;72: 343-6.
12. Tillie-Leblond I, Marquette CH, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006;144: 390-6.
13. Rutschmann OT, Cornuz J, Poletti PA, et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax 2007;62:121-5.
14. Hartmann IJ, Hagen PJ, Melissant CF, et al. Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in new technologies evaluating the localization of pulmonary embolism. Am J Respir Crit Care Med 2000;162:2232-7.
15. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood 2009;113:2878-87.
16. Rabe KF, Hurd S, Anzueto A, et al;GOLD Scientific Committee. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2001;163:1256-76.
17. Gibson NS, Sohne M, Kruip MJ, et al. Christopher study investigators. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008;99:229-34.
18. Akgun M, Meral M, Onbas O, et al Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism. Respiration 2006;73:428-33.
19. Raimondi P, Bongard O, de Moerloose P, et al. D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 1993;69:125-30.
20. Rohde G, Borg I, Wiethege A, et al. Inflammatory response in acute viral exacerbations of COPD. Infection 2008;36:427-33.
21. Shilon Y, Shitrit AB, Rudensky B, et al. A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia. Blood Coagul Fibrinolysis 2003;14:745-8.
22. Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest 2004;126:1087-92.
23. Piras O, Travaglino F, Autunno A, et al. Chronic systemic inflammatory syndrome in patients with AECOPD presenting to emergency department. Eur Rev Med Pharmacol Sci 2012;16(suppl 1):57-61.
24. Sin DD, Man SF. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008; 14:115-21.
25. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245-57.
26. Fimognari FL, Scarlata S, Conte ME, et al Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:89-96.
27. Kunter E, Ilvan A, Ozmen N, et al. Effect of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation. Respiration 2008;75:145-54.
28. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003;22:809-14.